Analyst Research

Report Title Price
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Directors Deals Ltd.
$12.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sorin SpA says received CE mark approval and first implant of new MRI compatible pacing system KORA 100


Wednesday, 27 Nov 2013 03:29am EST 

Sorin SpA:Says it announced CE (Conformite Europeenne) Mark approval and first implant of the KORA 100 pacing system.Says KORA 100 SR and DR pacemakers when implanted with the Sorin BEFLEX pacing lead enable implanted patients to undergo magnetic resonance imaging (MRI) safely.Says pacemaker patients are typically older than 65 years and this patient population is prone to other medical conditions such as arthritis, cancer or stroke that may require MRI examinations for optimal diagnosis and management. 

Company Quote

1.893
-0.027 -1.41%
6:20am EDT